Navigation Links
Sanofi-aventis U.S. Announces Increased Access to Drugs for Low Income Patients Through Expanded PAP Programs
Date:12/15/2008

BRIDGEWATER, N.J., Dec. 15 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S., an affiliate of sanofi-aventis, one of the world's leading pharmaceutical companies, announced today that starting January 1, 2009, it has increased access to its non-oncology Patient Assistance Programs (PAP)s to include eligible uninsured patients with incomes up to 250% of the Federal Poverty Level.

These PAPs assist patients with limited financial resources in gaining access to needed sanofi-aventis U.S. prescription medicines by focusing on individual patients and acting as a resource for those patients and their advocates. Uninsured individuals with income levels of up to $26,000 and uninsured families of four with combined income of up to $53,000 may be eligible to receive sanofi-aventis U.S. prescription drugs at no charge through the expanded U.S. Traditional PAP.*

"Sanofi-aventis U.S. remains committed to making our prescription medicines available to uninsured and low income patients through our PAPs," stated Greg Irace, President and CEO of sanofi-aventis U.S. "We have taken several steps to help patients with the greatest financial need access these medications."

The sanofi-aventis U.S. Patient Assistance Programs include medicines for many different disease states, including: Diabetes, Rheumatoid Arthritis, Urology, Dermatology, Blood Clotting (Deep Vein Thrombosis, Pulmonary Embolism), and Allergies. For more information, please contact the sanofi-aventis U.S. Traditional PAP at 1-800-221-4025.

PACT+(R) (Providing Access to Cancer Therapy), is Sanofi-aventis U.S.'s PAP for Cancer medications. PACT+ provides access to our oncology brands for eligible low income patients with an income of no greater than 500 percent of the Federal Poverty Level. PACT+ also provides reimbursement support services plus offers help in identifying a variety of alternative services and resources to support the specific needs of cancer patients. For more information on PACT+, please call 1-800-996-6626.

In addition, sanofi-aventis U.S. is a proud participant in The Partnership for Prescription Assistance which brings together America's pharmaceutical companies, doctors, other health care providers, patient advocacy organizations and community groups to help qualifying patients who lack prescription coverage get the medicines they need through the public or private program that's right for them. Call 1-888-477-2669 or visit www.pparx.org.

*Federal Poverty Limits change annually and are issued by the US Department of Health and Human Services.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). For more information, visit: www.sanofi-aventis.us or www.sanofi-aventis.com

Contact: Marc Greene, sanofi-aventis, 212-551-4780


'/>"/>
SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care
2. Welvista Announces Partnering with sanofi-aventis U.S. to Provide Medication at No Cost to the Uninsured
3. Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1):
4. Sanofi-aventis Teams With HHS Quality Agency to Distribute Consumer Health Materials
5. Sanofi-aventis Named One of Best Employers for Healthy Lifestyles by National Business Group on Health
6. Sanofi-aventis: Encouraging First-Quarter 2008 Results Further Positive Phase III Results for Eplivanserin
7. TechTeam Global Will Provide Multilingual EDC Support Services for sanofi-aventis recherche & developpement
8. Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp Rise in Proposed Dividend
9. Sanofi-aventis Announces a Good Third Quarter Performance; Increase in 2007 full-year earnings growth guidance
10. Sanofi-aventis US Chairman Tim Rothwell Addresses CMSAs Collaborative Practice Summit
11. Sanofi-Aventis renews licenses for Genomatix chip analysis pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... ... July 28, 2017 , ... Shamanic Teacher ... and Spiritual Awakening, is proud to announce the return of her increasingly ... interested in learning more about the mystical world of shamanism, nature wisdom, the ...
(Date:7/27/2017)... ... July 27, 2017 , ... Standard Process is ushering in a new ... the North Carolina Research Campus (NCRC) in Kannapolis, North Carolina and by announcing a ... the fall of this year, occupying over 10,000 square feet on the first floor ...
(Date:7/27/2017)... ... July 27, 2017 , ... Somnoware, a leading ... (PSG) distributed scoring solution to its healthcare management platform. This solution provides physicians ... speed and functionality of scoring in the cloud is on par with doing ...
(Date:7/27/2017)... ... ... eating isn’t always easy. Currently, more than 80 percent of Americans fail to eat the ... and sugar. This trend may help explain why the obesity rate seems stuck. The most ... a culture, we seem to have food on the brain more. "We eat two more ...
(Date:7/27/2017)... NY (PRWEB) , ... July 27, 2017 , ... ... President Barack Obama from 2012-2016, will keynote Day 2 of the HIMSS Healthcare ... event kicks off at the Sheraton Boston Hotel, Sept. 11-13, 2017. , Daniel ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... -- Bayer has awarded grants totaling more than $2 million to ... Bayer Hemophilia Awards Program (BHAP). Four U.S. clinicians and researchers ... and Uniformed Services University of the Health Sciences in ... were announced last night during a reception at the International ... Berlin, Germany . ...
(Date:7/11/2017)... July 11, 2017  Dr. Echenberg, founder of Echenberg Institute, is announcing ... patients who suffer from painful intercourse and other painful pelvic pain conditions ... due to menopause. ... VuVatech LLC ... Sarasota, Florida -based start-up company, VuVatech LLC, fills a ...
(Date:7/10/2017)... GAITHERSBURG, Md. , July 10, 2017 ... in non-animal test methods, is the recipient of a ... by the PETA International Science Consortium. The device, which ... be used to expose human lung cells to airborne ... lung. IIVS will use the VITROCELL® system for testing ...
Breaking Medicine Technology: